Logo image of ILMN

ILLUMINA INC (ILMN) Stock Price, Quote, News and Overview

NASDAQ:ILMN - Nasdaq - US4523271090 - Common Stock - Currency: USD

94.2  -3 (-3.09%)

After market: 93.67 -0.53 (-0.56%)

ILMN Quote, Performance and Key Statistics

ILLUMINA INC

NASDAQ:ILMN (2/21/2025, 8:00:01 PM)

After market: 93.67 -0.53 (-0.56%)

94.2

-3 (-3.09%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High156.66
52 Week Low93.5
Market Cap14.94B
Shares158.60M
Float157.96M
Yearly DividendN/A
Dividend YieldN/A
PE38.45
Fwd PE20.42
Earnings (Next)04-30 2025-04-30/amc
IPO06-28 2000-06-28


ILMN short term performance overview.The bars show the price performance of ILMN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

ILMN long term performance overview.The bars show the price performance of ILMN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of ILMN is 94.2 USD. In the past month the price decreased by -30.1%. In the past year, price decreased by -29.17%.

ILLUMINA INC / ILMN Daily stock chart

ILMN Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 24.36 203.70B
DHR DANAHER CORP 28.07 151.18B
A AGILENT TECHNOLOGIES INC 25.59 38.62B
IQV IQVIA HOLDINGS INC 17.15 33.64B
MTD METTLER-TOLEDO INTERNATIONAL 31.26 26.91B
WAT WATERS CORP 31.58 22.26B
ICLR ICON PLC 14.39 16.63B
WST WEST PHARMACEUTICAL SERVICES 31.25 15.27B
RVTY REVVITY INC 23.23 13.85B
AVTR AVANTOR INC 17.3 11.78B
TEM TEMPUS AI INC N/A 10.72B
MEDP MEDPACE HOLDINGS INC 26.94 10.37B

About ILMN

Company Profile

ILMN logo image Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 10,590 full-time employees. The company went IPO on 2000-06-28. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. The company is also a developer of an emerging and highly differentiated single-cell technology.

Company Info

ILLUMINA INC

5200 Illumina Way

San Diego CALIFORNIA 92122 US

CEO: Francis A. deSouza

Employees: 10615

Company Website: https://www.illumina.com

Investor Relations: https://investor.illumina.com

Phone: 18582024500

ILLUMINA INC / ILMN FAQ

What is the stock price of ILLUMINA INC today?

The current stock price of ILMN is 94.2 USD. The price decreased by -3.09% in the last trading session.


What is the ticker symbol for ILLUMINA INC stock?

The exchange symbol of ILLUMINA INC is ILMN and it is listed on the Nasdaq exchange.


On which exchange is ILMN stock listed?

ILMN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ILLUMINA INC stock?

32 analysts have analysed ILMN and the average price target is 165.5 USD. This implies a price increase of 75.69% is expected in the next year compared to the current price of 94.2. Check the ILLUMINA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ILLUMINA INC worth?

ILLUMINA INC (ILMN) has a market capitalization of 14.94B USD. This makes ILMN a Large Cap stock.


How many employees does ILLUMINA INC have?

ILLUMINA INC (ILMN) currently has 10615 employees.


What are the support and resistance levels for ILLUMINA INC (ILMN) stock?

ILLUMINA INC (ILMN) has a resistance level at 136.54. Check the full technical report for a detailed analysis of ILMN support and resistance levels.


Is ILLUMINA INC (ILMN) expected to grow?

The Revenue of ILLUMINA INC (ILMN) is expected to grow by 1.5% in the next year. Check the estimates tab for more information on the ILMN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ILLUMINA INC (ILMN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ILLUMINA INC (ILMN) stock pay dividends?

ILMN does not pay a dividend.


When does ILLUMINA INC (ILMN) report earnings?

ILLUMINA INC (ILMN) will report earnings on 2025-04-30, after the market close.


What is the Price/Earnings (PE) ratio of ILLUMINA INC (ILMN)?

The PE ratio for ILLUMINA INC (ILMN) is 38.45. This is based on the reported non-GAAP earnings per share of 2.45 and the current share price of 94.2 USD. Check the full fundamental report for a full analysis of the valuation metrics for ILMN.


What is the Short Interest ratio of ILLUMINA INC (ILMN) stock?

The outstanding short interest for ILLUMINA INC (ILMN) is 4.12% of its float. Check the ownership tab for more information on the ILMN short interest.


ILMN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ILMN Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to ILMN. ILMN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ILMN Financial Highlights

Over the last trailing twelve months ILMN reported a non-GAAP Earnings per Share(EPS) of 2.45. The EPS increased by 181.61% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -26.34%
ROE -74.54%
Debt/Equity 0.94
Chartmill High Growth Momentum
EPS Q2Q%514.29%
Sales Q2Q%-1.6%
EPS 1Y (TTM)181.61%
Revenue 1Y (TTM)-2.93%

ILMN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 76% to ILMN. The Buy consensus is the average rating of analysts ratings from 32 analysts.

For the next year, analysts expect an EPS growth of 88.3% and a revenue growth 1.5% for ILMN


Ownership
Inst Owners93.19%
Ins Owners0.14%
Short Float %4.12%
Short Ratio2.83
Analysts
Analysts76.25
Price Target165.5 (75.69%)
EPS Next Y88.3%
Revenue Next Year1.5%